Amount Raised
$50 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, today announced the completion of a $50 million Series B financing.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Casma Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Rezolute raised $41M on October 22, 2020.
- OncoNano Medicine raised $49M on October 21, 2020.
- Nuvation Bio raised $275M on October 20, 2020.
- HCW Biologics raised $6.2M on October 19, 2020.
- Olema Pharmaceuticals, Inc. raised $87M on October 13, 2020.
- Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
Who to call at Casma Therapeutics, and when
A new round usually means Casma Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Casma Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Casma Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Casma Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Casma Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCasma Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.